Skip to main content Skip to footer

Commercial, sales & marketing services

The new era of commercialization

What is driving this change?

A new growth era

47%

ranked advancing the sophistication of pricing and market access as one of their top three priorities to drive future commercial success

58%

ranked stronger adoption of data and analytics capabilities to fuel decisions and operations as one of their top three investment priorities

48%

said product launch capability received the greatest increase in technology investment over the past 12 months

30%

ranked talent as top aspect of operating model critical for growth

20%

of respondents cited sustainability and more equitable access as their top net new priority without being prompted

40%

of executives said they see their organization shifting to be more focused on transformation

PANEL DISCUSSION 

The next era of commercialization

Actions to modernize

Aligning evidence and economics to outcomes

Demonstrate outcomes through value-based models and access led transformation.

Bringing outcomes to life through experience

Designing experiences around the changing needs of patients, caregivers, and HCPs across increasingly complex care pathways.

Modernizing launch and competitive strategies

Optimizing market entry by empowering brand teams with therapeutic area expertise and executing flawlessly.

Reinventing end to end marketing

Moving away from traditional marketing tactics to positioning assets to drive growth.

Reimagining the digitized customer model

Introducing new engagement approaches to better support HCPs and patients.

Applying intelligence to commercial

Playing data offense and leaning into artificial intelligence (AI) to streamline operations.

Rewiring operations and capabilities

Strengthening core capabilities to promote and sustain commercial growth.

“While we are rarely wrong about the direction of change in healthcare, we are almost always wrong about its velocity.”

— RAY PRESSBURGER, Accenture Strategy, Commercial, Sales and Marketing, Life Sciences

What we think

Read

Digital Health: The future of healthcare

Digital Health sits at the convergence of medicine and technology. Read our report to learn how MedTech will shape the future of digital health.

Read
Read

Reinventing Enterprise Operations

Find out how optimizing operations can help to access a new performance frontier.

Read
Read

Generative AI technology in business

A look ahead at the fast-paced evolution of technology, regulation, and business.

Read
Read

Together we can: Data Collaboratives

How best do health ecosystem players access data to fast-forward healthcare? Data Collaboratives could be the answer.

Read

Our leaders

Ramon Pressburger

Managing Director – North America Lead and Strategy Lead, Global Life Sciences

Jimmy Paras

Managing Director – Consulting, Life Sciences, Commercial Services, North America

Laura Dix

Managing Director – Life Sciences, United Kingdom

Gro Blindheim

Managing Director, Global Bayer Account Lead and Global Life Science Commercial Lead

Vinita Vasanth

Managing Director – Asia Pacific, Global Life Sciences

Floren Robinson Pressman

Managing Director – Life Sciences Accenture Song Lead, NA

Rich Sherman

Managing Director – Intelligent Patient Services Digital Health Applications

Suzy Jackson

Managing Director – Life Sciences

Christina Chou

North America Commercial Strategy

Frequently asked questions